Literature DB >> 17359903

Relationship between DNA damage and total antioxidant capacity in patients with glioblastoma multiforme.

S Tuzgen1, H Hanimoglu, T Tanriverdi, T Kacira, G Z Sanus, P Atukeren, R Dashti, K Gumustas, B Canbaz, M Y Kaynar.   

Abstract

AIMS: To assess oxidative DNA damage and total antioxidant capacity (TAC) in glioblastoma multiforme (GBM) and to compare the results with normal brain tissues.
MATERIALS AND METHODS: Oxidative DNA damage and TAC were evaluated in GBM tissues extracted from 26 patients and in normal brain tissues of 15 subjects who underwent autopsy within the first 4h of death. Oxidative DNA damage was assessed by measuring 8-hydroxy-2-deoxyguanosine (8-OH-dG) using the 8-OH-dG enzyme immunoassay kit, a quantitative assay for 8-OH-dG, and TAC was analysed using the ImAnOx colorimetric test system for the determination of antioxidative capacity. The results were compared between two groups and any correlation between 8-OH-dG and TAC was sought.
RESULTS: The median level of TAC in GBM (121.5 nmol/g wet tissue) was remarkably lower than that in normal brain tissue (298 nmol/g wet tissue). The difference was statistically significant (P=0.00001). In contrast, oxidative DNA damage was significantly higher in patients with GBM (74.9 ng/g wet tissue) than in controls (34.71 ng/g wet tissue). Again, the difference was statistically significant (P=0.00001). We also found a negative correlation between oxidative DNA damage and TAC (P<0.001).
CONCLUSIONS: These findings indicate that the degree of oxidative DNA damage is increased and TAC is decreased in GBM. Oxidative DNA damage is correlated with the levels of TAC.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17359903     DOI: 10.1016/j.clon.2006.11.012

Source DB:  PubMed          Journal:  Clin Oncol (R Coll Radiol)        ISSN: 0936-6555            Impact factor:   4.126


  7 in total

1.  8-Hydroxy-2-deoxy-guanosine identifies oxidative DNA damage in a rural prediabetes cohort.

Authors:  Hayder A Al-Aubaidy; Herbert F Jelinek
Journal:  Redox Rep       Date:  2010       Impact factor: 4.412

2.  Muscadine Grape Skin Extract (MPX) in Men with Biochemically Recurrent Prostate Cancer: A Randomized, Multicenter, Placebo-Controlled Clinical Trial.

Authors:  Channing J Paller; Xian C Zhou; Elisabeth I Heath; Mary-Ellen Taplin; Tina Mayer; Mark N Stein; Glenn J Bubley; Roberto Pili; Tamaro Hudson; Radhika Kakarla; Muneer M Abbas; Nicole M Anders; Donna Dowling; Serina King; Ashley B Bruns; William D Wagner; Charles G Drake; Emmanuel S Antonarakis; Mario A Eisenberger; Samuel R Denmeade; Michelle A Rudek; Gary L Rosner; Michael A Carducci
Journal:  Clin Cancer Res       Date:  2017-11-07       Impact factor: 12.531

3.  Protective effect of allicin on high glucose/hypoxia-induced aortic endothelial cells via reduction of oxidative stress.

Authors:  Shu-Li Wang; DE-Shan Liu; Er-Shun Liang; Yan-Hua Gao; Ying Cui; Yu-Zhao Liu; Wei Gao
Journal:  Exp Ther Med       Date:  2015-08-24       Impact factor: 2.447

4.  Targeting NRF2, Regulator of Antioxidant System, to Sensitize Glioblastoma Neurosphere Cells to Radiation-Induced Oxidative Stress.

Authors:  Paulo R D V Godoy; Ali Pour Khavari; Marzia Rizzo; Elza T Sakamoto-Hojo; Siamak Haghdoost
Journal:  Oxid Med Cell Longev       Date:  2020-06-15       Impact factor: 6.543

5.  The Therapeutic Potential of Aprepitant in Glioblastoma Cancer Cells through Redox Modification.

Authors:  Soodabeh Rezaei; Reza Assaran Darban; Hossein Javid; Seyed Isaac Hashemy
Journal:  Biomed Res Int       Date:  2022-03-03       Impact factor: 3.411

6.  Oxidative damage and carcinogenesis.

Authors:  Joanna Katarzyna Strzelczyk; Andrzej Wiczkowski
Journal:  Contemp Oncol (Pozn)       Date:  2012-07-06

7.  Salivary analysis of oral cancer biomarkers.

Authors:  T Shpitzer; Y Hamzany; G Bahar; R Feinmesser; D Savulescu; I Borovoi; M Gavish; R M Nagler
Journal:  Br J Cancer       Date:  2009-10-06       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.